BRCA1 and familial pancreatic carcinoma: Most of the previous studies conducted for the detection of BRCA1/BRCA2 mutations in pancreatic cancer were performed in patients with a strong family history of the disease or in individuals with Ashkenazi Jewish ancestry and the reported prevalence of BRCA mutations is variable, ranging from 13% to 19% [27–30].